Given the striking protection elicited by exogenous IL-33 treatment, we additionally asked whether endogenous IL-33 signaling contributes to survival from CDI using transgenic mice lacking the IL-33 receptor, ST2−/−. This evidence concerns the gene IL33 and clostridium difficile infection.